opportunityanalyzer: bladder cancer - opportunity analysis and forecasts to 2017
DESCRIPTION
Bladder Cancer Market in the 6MM to rech $297.5m in 2017, Reveals New Report See more at: http://goo.gl/uV06mhTRANSCRIPT
www.MarketResearchReports.com
Opportunity Analyzer: Bladder
Cancer - Opportunity Analysis and
Forecasts to 2017
Category : Healthcare
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Introduction to Report
Launch Date: December 31, 2013
Number of Pages: 158
Geography Coverage: Global
Available Format: PDF
Price For Single User License: USD 5,995
Price For Site License: USD 11,990
Price For Global User License: USD 14,400
Delivery Time: Within 24 Hours (During Working Days)
www.MarketResearchReports.com
Key Questions Answered• Which bladder cancer patient segments have the
greatest unmet needs?
• What are the R&D strategies companies are pursuing in the bladder cancer space?
• Why has there been a void of interest from big pharma in this highly underserved market?
• What are the most promising pipeline agents for bladder cancer? How do their clinical and commercial attributes compare to one another?
• What opportunities will remain for future players following the launch of these pipeline agents?
• What is the potential for predictive biomarkers and targeted therapies in the bladder cancer setting?
www.MarketResearchReports.com
Research Findings
GlobalData forecasts the bladder cancer market in the 6MM to grow modestly from $239.3m in 2012 to $297.5m in 2017, at a CAGR of 4%.
The main driver of growth in the global bladder cancer market will be the increase in number of incident cases across the study period in the 6MM and the entrance of EOquin into the market towards the end of the forecast period.
Although the level of unmet need in the bladder cancer market is high, KOLs are generally not impressed by any of the pipeline products and they do not expect any of them to drastically change the treatment landscape. The unmet needs will hence remain after the forecast period in turn rendering the bladder cancer market as highly lucrative and commercially viable for developers.
www.MarketResearchReports.com
Scope Overview of bladder cancer, including epidemiology, etiology,
pathophysiology, symptoms, diagnosis, and disease management.
Topline bladder cancer therapeutics market revenue from 2012–2017. Annual cost of therapy, and major marketed and pipeline drug sales in this forecast period are included.
Key topics covered include strategic competitor assessment, market characterization, unmet needs, R&D strategies, and clinical trial design for the bladder cancer therapeutics market.
Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, synopses of innovative early-stage projects, and detailed analysis of late-stage pipeline drugs. An interactive clinical and commercial analyzer tool is available.
Analysis of the current and future market competition in the global bladder cancer market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
www.MarketResearchReports.com
Reasons to Buy Develop and design your in-licensing and out-licensing
strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the global bladder cancer market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global bladder cancer therapeutics market in the future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments
www.MarketResearchReports.com
Report Coverage
1. Introduction
2. Disease Overview
3. Epidemiology
4. Current Treatment Options
5. Unmet Needs Assessment and Opportunity Analysis
6. R&D Strategies
7. Pipeline Assessment
8. Pipeline Valuation Analysis
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Custom Research: Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.
For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center
www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and purchase this publication:
http://www.marketresearchreports.com/globaldata/opportunityanalyzer-bladder-cancer-opportunity-analysis-and-forecasts-2017
About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.
Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)